PTPN2 Loss Sensitizes Tumor Cells to Immunotherapy [Immunotherapy]

Ptpn2 loss increases tumor cell IFN signaling to enhance antigen presentation and antitumor immunity.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: Immunotherapy Source Type: research